EMCURE - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.8
| Stock Code | EMCURE | Market Cap | 32,690 Cr. | Current Price | 1,724 ₹ | High / Low | 1,830 ₹ |
| Stock P/E | 43.5 | Book Value | 196 ₹ | Dividend Yield | 0.17 % | ROCE | 23.7 % |
| ROE | 22.3 % | Face Value | 10.0 ₹ | DMA 50 | 1,635 ₹ | DMA 200 | 1,489 ₹ |
| Chg in FII Hold | -0.24 % | Chg in DII Hold | 0.00 % | PAT Qtr | 228 Cr. | PAT Prev Qtr | 282 Cr. |
| RSI | 56.0 | MACD | 28.2 | Volume | 1,55,640 | Avg Vol 1Wk | 99,601 |
| Low price | 1,229 ₹ | High price | 1,830 ₹ | PEG Ratio | 0.66 | Debt to equity | 0.43 |
| 52w Index | 82.4 % | Qtr Profit Var | 63.4 % | EPS | 38.7 ₹ | Industry PE | 31.6 |
Chart & Trend Analysis:
EMCURE is trading at ₹1,724, above both its 50 DMA (₹1,635) and 200 DMA (₹1,489), confirming bullish momentum. RSI at 56.0 indicates healthy strength without being overbought. MACD at 28.2 shows positive crossover, supporting upward momentum. Bollinger Bands are widening, reflecting volatility expansion. Current volume (1.55L) is higher than the weekly average (99.6K), showing strong participation.
Momentum Signals:
- RSI above 55 signals bullish continuation.
- MACD positive, confirming momentum strength.
- Resistance zones: ₹1,750–1,770 (short-term), ₹1,800–1,830 (major).
- Support zones: ₹1,680–1,700 immediate, deeper support at ₹1,635 (50 DMA).
- Trend status: Strong uptrend with potential consolidation near resistance.
Entry Zone: ₹1,680–1,700 (ideal accumulation zone)
Exit Zone: ₹1,770–1,830 (profit booking zone)
Stop-Loss: Below ₹1,635
Positive
- Strong ROCE (23.7%) and ROE (22.3%) highlight efficient capital use.
- EPS at ₹38.7 reflects robust earnings power.
- PEG ratio at 0.66 suggests attractive valuation relative to growth.
- Price strength supported by both 50 DMA and 200 DMA alignment.
Limitation
- Quarterly PAT declined (₹228 Cr vs ₹282 Cr), showing earnings pressure.
- FII holdings decreased (-0.24%), indicating cautious foreign sentiment.
- Debt-to-equity ratio at 0.43 is higher than peers, adding financial risk.
Company Negative News
- Sequential decline in quarterly profits highlights margin pressure.
- Reduced FII participation may limit near-term upside.
Company Positive News
- Strong fundamentals with consistent profitability and efficiency ratios.
- EPS growth supports valuation strength.
Industry
- Industry PE at 31.6 is lower than EMCURE’s P/E (43.5), suggesting premium valuation.
- Pharma sector remains resilient with strong demand drivers.
Conclusion
EMCURE is in a bullish trend, trading above key moving averages with supportive RSI and MACD signals. Entry near ₹1,680–1,700 offers a favorable risk-reward setup, with exit potential around ₹1,770–1,830. Fundamentals remain strong, making it suitable for swing trades and medium-term holdings, though premium valuation and debt levels require cautious monitoring.
Would you like me to extend this into a short-term intraday setup, a swing trade roadmap, or a fundamental deep dive?